Corneal endothelial deposits associated with rifabutin treatment in Crohn's disease [5]

Eye

Volumn 20, Issue 2, 2006, Pages 250-252

  Mitra, Arijit ^a,b   Ghosh, Y K ^a   McElvanney, A M ^a  

^a ROYAL OLDHAM HOSPITAL   (United Kingdom)

^b EPSOM AND ST HELIER UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

RIFABUTIN;

ADULT; ANAMNESIS; CASE REPORT; CORNEA DISEASE; CORNEA ENDOTHELIUM; CROHN DISEASE; DRUG WITHDRAWAL; FEMALE; HUMAN; LETTER; OUTCOME ASSESSMENT; PATIENT REFERRAL; TREATMENT DURATION; VISUAL ACUITY; VISUAL SYSTEM EXAMINATION;

EID: 33646262313     PISSN: 0950222X     EISSN: 14765454     Source Type: Journal    
DOI: 10.1038/sj.eye.6701826     Document Type: Letter

References (6)

1. Ponjavic V, Granse L, Bengtsson Stigmar E, Amdreasson S. Retinal dysfunction and anterior segment deposits in a patient treated with rifabutin. Acta Ophthalmol Scand 2002; 80(5): 553-556.
2. Hermon-Taylor J. Treatment with drugs active against Mycobacterium avium subspecies paratuberculosis can heal Crohn's disease: More evidence for a neglected public health tragedy. Dig Liver Dis 2002; 34(1): 9-12.
3. Smith JA, Mueller BU, Nussenblatt RB, Whitcup SM. Corneal endothelial deposits in children positive for human immunodeficiency virus receiving rifabutin prophylaxis for Mycobacterium avium complex bacteremia. Am J Ophthalmol 1999; 127(2): 164-169.
4. Holland SP, Chang CW, Vagh M, Courtright P, for St Paul's Ocular AIDS Group. Corneal endothelial deposits in patients with HIV infection Or AIDS: Epidemiologic evidence of the contribution of rifabutin. Can J Ophthalmol 1999; 34(4): 204-209.
5. Golchin B, MClellan K. Corneal endothelial deposits secondary to rifabutin prophylaxis for Mycobacterium avium complex bacteraemia. Br J Ophthalmol 2003; 87(6): 798-799.
6. Walter KA, Coulter VI, Palay PA, Taravella MJ, Grossniklaus HE, Edelhauser HF. Corneal endothelial deposits in patients with cytomegalovirus retinitis. Am J Ophthalmol 1996; 121: 391-396.